Contrast-induced Nephropathy
📧 Sign up to get email alerts when something new happens for Contrast-induced Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-04-20Clinical Trial Update: Renoprotective Effects of Fluid Prophylaxis Strategies for Contrast Induced Nephropathy (CIN) [Phase 4]
Phase 4 trial evaluating fluid prophylaxis strategies to prevent Contrast Induced Nephropathy was withdrawn from the study status.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: A Randomized Trial of Rosuvastatin in Elective Angioplasty to Prevent Contrast-induced Nephropathy (CLEAR-CIN). [Phase 4]
A Phase 4 randomized trial assessed whether rosuvastatin reduces the risk of contrast-induced nephropathy in patients undergoing elective an…
-
CLINICAL_TRIALS research · 2016-03-18Clinical Trial Update: Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Nephropathy [NA]
A completed clinical trial evaluated neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for detecting contrast-induced nephrop…
-
CLINICAL_TRIALS research · 2016-01-08Clinical Trial Update: Aging Biomakers and ConTrast Induced Nephropathy (ACTIN) Trial
The ACTIN trial investigating aging biomarkers and contrast-induced nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Does Bicarbonate in Addition to Theophylline Reduce CIN? [NA]
A completed clinical trial tested whether adding bicarbonate to theophylline reduces contrast-induced nephropathy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-12-31Clinical Trial Update: Relationship Between ALDH2 and CIN
A clinical trial is investigating the relationship between ALDH2 and contrast-induced nephropathy. The status of the study is currently unkn…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Personalized Versus Standard Hydration for Prevention of CI-AKI: a Randomized Trial With Bioimpedance Analysis [Phase 4]
Phase 4 randomized trial comparing personalized hydration guided by bioimpedance analysis to standard hydration for prevention of contrast-i…
-
CLINICAL_TRIALS trial_result · 2015-10-16Clinical Trial Update: Statins for Prevention of Contrast Induced Nephropathy [Phase 4]
Phase 4 clinical trial evaluating statins for prevention of contrast-induced nephropathy. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial [Phase 4]
A completed Phase 4 randomized trial evaluated prophylaxis with N-acetylcysteine, sodium bicarbonate, and normal saline to prevent contrast-…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Renin-angiotensin-aldosterone System (RAAS) Blockade and Contrast Induced Nephropathy [NA]
Completed clinical trial evaluating whether RAAS blockade influences the incidence of radiographic contrast-induced nephropathy.
-
CLINICAL_TRIALS research · 2015-05-14Clinical Trial Update: Folic Acid for Prevention of Contrast Induced Nephropathy [Phase 4]
Phase 4 clinical trial update evaluating folic acid for prevention of contrast-induced nephropathy.
-
CLINICAL_TRIALS withdrawal · 2015-04-08Clinical Trial Update: Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography [NA]
A clinical trial investigating the renal protective effect of pentoxifylline in high-risk patients undergoing angiography has been withdrawn…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Central Venous Pressure Guided Hydration Prevention for Contrast-Induced Nephropathy [NA]
A completed clinical trial evaluating central venous pressure-guided hydration to prevent contrast-induced nephropathy in patients with Card…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy [NA]
A clinical trial comparing oral hydration to intravenous hydration for prevention of contrast-induced nephropathy was terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Prevention of Contrast Renal Injury With Different Hydration Strategies [Phase 3]
A Phase 3 clinical trial comparing different hydration strategies to prevent contrast-induced nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate [Phase 3]
A Phase 3 clinical trial evaluating sodium bicarbonate to prevent contrast-induced nephropathy has completed.
-
CLINICAL_TRIALS withdrawal · 2015-03-11Clinical Trial Update: Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage [Phase 2]
Phase 2 trial evaluating intravenous amino acid infusion to prevent contrast-induced nephropathy has been withdrawn.
-
CLINICAL_TRIALS research · 2015-02-12Clinical Trial Update: Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP [Phase 4]
Phase 4 clinical trial evaluating prevention of contrast-induced nephropathy during diagnostic coronary angiography or PCI using hydration g…
-
CLINICAL_TRIALS research · 2014-09-16Clinical Trial Update: Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury [Phase 3]
A Phase 3 trial is evaluating whether N-acetylcysteine and sodium bicarbonate can prevent contrast-induced acute kidney injury in patients w…
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: PREdictive Value of COntrast voluMe to creatinINe Clearance Ratio
The study evaluated whether the ratio of contrast volume to creatinine clearance can predict the risk of contrast-induced nephropathy. The t…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Metabolic Syndrome and Contrast Induced Nephropathy
An Ankara University–sponsored clinical trial examining metabolic syndrome and contrast-induced nephropathy has completed. The update notes …
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: Efficacy of Dexmedetomidine in Preventing Contrast Induced Nephropathy [Phase 4]
A Phase 4 clinical trial update reports on the efficacy of dexmedetomidine in preventing contrast-induced nephropathy.
-
CLINICAL_TRIALS research · 2014-04-15Clinical Trial Update: High Dose Atorvastatin for Preventing Contrast-induced Nephropathy [Phase 2, Phase 3]
Clinical trial update indicates completion of Phase 2 and Phase 3 studies evaluating high-dose atorvastatin for preventing contrast-induced …
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography [Phase 3]
Phase 3 clinical trial assessing whether atorvastatin can prevent contrast-induced nephropathy in patients undergoing coronary angiography.
-
CLINICAL_TRIALS research · 2014-03-17Clinical Trial Update: Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy [Phase 2, Phase 3]
A clinical trial update evaluating Theophylline, N-acetylcysteine, and their combination to prevent contrast-induced nephropathy, spanning P…